Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial-Reference-Cited by-同舟云学术

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial

Published:2011-09 Issue:9 Volume:12 Page:871-879
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Di Stasi Savino M,Valenti Marco,Verri Cristian,Liberati Emanuele,Giurioli Arcangelo,Leprini Gioia,Masedu Francesco,Ricci Antonio R,Micali Francesco,Vespasiani Giuseppe

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Global cancer statistics;Jemal;Ca Cancer J Clin,2011

2. EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. The health economics of bladder cancer: a comprehensive review of the published literature;Botteman;Pharmacoeconomic,2003

5. Susceptibility of urothelium to neoplastic cellular implantation;Weldon;Urology,1975

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy;Coordination Chemistry Reviews;2024-06

2. Drug‐Loaded Bacillus Calmette–Guérin Bacteria for Immuno‐Chemo Combo Therapy in Bladder Cancer;Advanced Materials;2024-02-16

3. Electromotive Drug Administration in the Porcine Renal Pelvis: First Report;Journal of Endourology;2024-01-01

4. First-line Intravesical Chemotherapy for Non–muscle-invasive Bladder Cancer: Chimera or “Ne Plus Ultra”?;European Urology;2023-07

5. Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer;Bladder Cancer;2023-06-27